Evidence map›Paper›PMID 42512351›Full record

ArticleCancers2026

The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLC.

Melina E Marmarelis, Adrienne M Gilligan, Tomoko Sugihara, Tyler Marquart, Sam Whipple, Yufei Wang, Taylor J Allen-Coyle, Naleen Raj Bhandari, Charu Aggarwal

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Melina E MarmarelisPerelman Center for Advanced Medicine, Philadelphia, PA 19104, USA.ORCID 0000-0003-2187-3583
Adrienne M GilliganEli Lilly and Company, Indianapolis, IN 46285, USA.
Tomoko SugiharaSyneos Health, Morrisville, NC 27560, USA.
Tyler MarquartEli Lilly and Company, Indianapolis, IN 46285, USA.
Sam WhippleEli Lilly and Company, Indianapolis, IN 46285, USA.
Yufei WangEli Lilly and Company, Indianapolis, IN 46285, USA.
Taylor J Allen-CoyleEli Lilly and Company, Indianapolis, IN 46285, USA.
Naleen Raj BhandariEli Lilly and Company, Indianapolis, IN 46285, USA.ORCID 0000-0002-4452-8021
Charu AggarwalPerelman Center for Advanced Medicine, Philadelphia, PA 19104, USA.

Funding

Eli Lilly (United States)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

next-generation sequencingNSCLCoverallreal-world evidencetargeted therapyturnaround time

Identifiers

PMID42512351
PMCPMC13407332

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.